3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Venous Thromboembolism
1
TP53 Y220C Mutation
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Pulmonary Embolism
1
Prostatic Neoplasms, Castration-Resistant
1
Peripheral Nervous System Diseases
1
Neoplasms
1
Liver Cirrhosis
1
Leiomyosarcoma
1
Healthy Participants
1
Healthy Adult Participants
1
Endometrial Neoplasms
1
Drug-drug Interaction,SHR3680
1
Cardiotoxicity
1
Breast Neoplasms
1
Advanced Solid Malignancies
1
Interventions
pembrolizumab
25
Cisplatin
20
Carboplatin
14
Paclitaxel
11
Radiotherapy
9
Radiotherapy, Intensity-Modulated
8
Docetaxel
8
Cetuximab
8
Nivolumab
6
cemiplimab
5
Radiation
5
durvalumab
4
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Fluorouracil
3
Drug Therapy
3
Cyclophosphamide
3
Blood Specimen Collection
3
toripalimab
2
olaparib
2
fludarabine
2
avelumab
2
alpha-2'-deoxythioguanosine
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Rosuvastatin Calcium
×
1 year
×
Clear all
No trials found.